Le Lézard
Classified in: Health
Subjects: PDT, PSF

Altrix Medical Releases Life Saving App for Opioid Overdoses


CENTREVILLE, Va., May 23, 2018 /PRNewswire/ -- Today, Altrix Medical, LLC announced the release of NaloxoFind, a free app for iPhone and Android platforms to assist communities in battling the opioid epidemic. NaloxoFind helps people witnessing an overdose to locate and contact naloxone carriers in emergency overdose situations. Naloxone is a medication that, if given in time, reverses an opioid overdose. Last month the Surgeon General's office issued its first advisory in thirteen years urging more Americans to carry naloxone.

NaloxoFind allows anyone to locate registered naloxone carriers within a two-mile radius, share GPS coordinates and communicate directly with them. It also provides an interface for anyone to register as a naloxone carrier.

Matthew Shaker, President of Altrix Medical, said "One hundred seventy-five people die from opioid overdoses every day, in part because naloxone isn't available when it's required. We're happy to be able to offer this app to help make sure this critical medicine is available when and where it is needed."

Altrix Medical is actively seeking community partners to help integrate NaloxoFind into opioid overdose training programs and augment emergency call centers with real-time online naloxone GPS and communication capabilities.

NaloxoFind is available on the Apple App Store for iOS devices and on Google Play for Android devices.

About Altrix Medical, LLC: Altrix Medical LLC was founded in May 2013 with the singular goal of leveraging innovative technologies and imaginative ideas to prevent and cure disease. Altrix Medical develops online applications and medical equipment with the goal of improving the quality of people's lives.

SOURCE Altrix Medical


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: